Literature DB >> 8740694

Retinoblastoma in Turkey: diagnosis and clinical characteristics.

I Günalp1, K Gündüz, Y Arslan.   

Abstract

Retinoblastoma (RB) is the most frequent malignant intraocular tumor in childhood. Six hundred and thirty-six cases with 831 RB-affected eyes were diagnosed and treated in our specialist center between 1963-1994. The diagnosis was made by histopathologic examination in 617 cases and clinically in 19 cases. Four hundred and forty-one (69.3%) cases were unilateral and 195 (30.7%) were bilateral. Two hundred and sixty-eight (42.1%) were females and 368 (57.9%) were males. The youngest patient was 20 days old and the oldest was 16 years old at the time of diagnosis (mean: 2.2 years). In thirty-four (5.3%) cases, a family history of RB was present. Ten of these cases were unilateral and 24 were bilateral. The most frequent presenting signs were leukocoria (394 cases, 61.9%), buphthalmos (92 cases, 14.5%), and strabismus (68 cases, 10.7%). The referring initial diagnoses were correct in 519 (81.6%) cases and false-negative in 117 (18.4%) cases. The most frequent initial false-negative diagnoses of the referring physicians were buphthalmos (43 cases, 6.8%), endophthalmitis (37 cases, 5.8%), and retinal detachment (12 cases, 1.9%). Apart from these 636 cases, there were 29 false-positive RB diagnoses during the same study period for which enucleation was performed. False-positive diagnoses included endophthalmitis (9 cases), retinal dysplasia (6 cases), retinal detachment (5 cases), vitreous hemorrhage (4 cases), Coats' disease (4 cases), and toxocariasis (one case). Ancillary testing for metastasis was carried out in all cases with newly diagnosed retinoblastoma. Five hundred and ninety-eight (72%) eyes had intraocular disease and 233 (28%) had extraocular spread. Of these 233 RBS, 58 had systemic disease. Fifty-two out of 58 tumors showing systemic involvement had either optic nerve or extrascleral extension at the histopathologic examination of enucleation material. The remaining six eyes had intraocular Class IV-V RB.

Entities:  

Mesh:

Year:  1996        PMID: 8740694     DOI: 10.3109/13816819609057865

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  6 in total

1.  A multicentre report from the Mexican Retinoblastoma Group.

Authors:  C Leal-Leal; M Flores-Rojo; A Medina-Sansón; F Cerecedo-Díaz; S Sánchez-Félix; O González-Ramella; F Pérez-Pérez; R Gómez-Martínez; A Quero-Hernández; E Altamirano-Alvarez; F Alejo-González; J Figueroa-Carbajal; A Ellis-Irigoyen; I Tejocote-Romero; R Cervantes-Paz; F Pantoja-Guillén; L Vega-Vega; F Carrete-Ramírez
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

2.  "Retinoblastoma survival disparity": The expanding horizon in developing countries.

Authors:  Masood Naseripour
Journal:  Saudi J Ophthalmol       Date:  2012-02-18

3.  Retinoblastoma in Children Older than 6 Years of Age.

Authors:  Rachna Meel; Seema Kashyap; Sameer Bakhshi; Mandeep Singh Bajaj; Meenakshi Wadhwani
Journal:  Ocul Oncol Pathol       Date:  2020-10-23

4.  Characteristics of Germline and Non-germline Retinoblastomas.

Authors:  Fariba Ghassemi; Hormoz Chams; Siamak Sabour; Reza Karkhaneh; Farzad Farzbod; Mehdi Khodaparast; Parvaneh Vosough
Journal:  J Ophthalmic Vis Res       Date:  2014-04

Review 5.  Retinoblastoma: achieving new standards with methods of chemotherapy.

Authors:  Swathi Kaliki; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

6.  Retinoblastoma: A Sixteen-Year Review of the Presentation, Treatment, and Outcome from a Tertiary Care Institute in Northern India.

Authors:  Usha Singh; Deeksha Katoch; Savleen Kaur; Mangat Ram Dogra; Deepak Bansal; Rakesh Kapoor
Journal:  Ocul Oncol Pathol       Date:  2017-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.